XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock Outstanding
Additional Paid-in Capital
Treasury Stock
Retained Earnings
AOCI Attributable to Parent
Total
Balances (in shares) at Dec. 31, 2020 36,850   9,550      
Balances at Dec. 31, 2020 $ 6 $ 407,173 $ (96,215) $ (76,233) $ (225) $ 234,506
Issuance of common stock in connection with employee stock purchase plan (in shares) 100          
Issuance of common stock in connection with employee stock purchase plan   921       921
Issuance of common stock in connection with exercise of options (in shares) 81          
Issuance of common stock in connection with exercise of options   568       568
Vesting of restricted stock units (in shares) 149          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     73      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (1,463)     (1,463)
Repurchase of common stock (in shares) (251)   251      
Repurchase of common stock     $ (4,523)     (4,523)
Stock-based compensation expense   3,369       3,369
Comprehensive income (loss)       (7,597) (528) (8,125)
Balances (in shares) at Mar. 31, 2021 36,929   9,874      
Balances at Mar. 31, 2021 $ 6 412,031 $ (102,201) (83,830) (753) 225,253
Balances (in shares) at Dec. 31, 2020 36,850   9,550      
Balances at Dec. 31, 2020 $ 6 407,173 $ (96,215) (76,233) (225) 234,506
Comprehensive income (loss)           (15,031)
Balances (in shares) at Sep. 30, 2021 37,274   9,974      
Balances at Sep. 30, 2021 $ 6 418,933 $ (103,995) (90,721) (768) 223,455
Balances (in shares) at Mar. 31, 2021 36,929   9,874      
Balances at Mar. 31, 2021 $ 6 412,031 $ (102,201) (83,830) (753) 225,253
Issuance of common stock in connection with exercise of options (in shares) 39          
Issuance of common stock in connection with exercise of options   290       290
Vesting of restricted stock units (in shares) 118          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     51      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (887)     (887)
Stock-based compensation expense   2,742       2,742
Comprehensive income (loss)       (4,484) 210 (4,274)
Balances (in shares) at Jun. 30, 2021 37,086   9,925      
Balances at Jun. 30, 2021 $ 6 415,063 $ (103,088) (88,314) (543) 223,124
Issuance of common stock in connection with employee stock purchase plan $ 9 114       114
Issuance of common stock in connection with exercise of options (in shares) 40          
Issuance of common stock in connection with exercise of options   393       393
Vesting of restricted stock units (in shares) 139          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     49      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (907)     (907)
Stock-based compensation expense   3,363       3,363
Comprehensive income (loss)       (2,407) (225) (2,632)
Balances (in shares) at Sep. 30, 2021 37,274   9,974      
Balances at Sep. 30, 2021 $ 6 418,933 $ (103,995) (90,721) (768) 223,455
Balances (in shares) at Dec. 31, 2021 37,411   10,003      
Balances at Dec. 31, 2021 $ 6 423,069 $ (104,705) (97,721) (1,064) 219,585
Issuance of common stock in connection with employee stock purchase plan (in shares) 95          
Issuance of common stock in connection with employee stock purchase plan   1,502       1,502
Issuance of common stock in connection with exercise of options (in shares) 75          
Issuance of common stock in connection with exercise of options   675       675
Vesting of restricted stock units (in shares) 232          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     113      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (3,389)     (3,389)
Repurchase of common stock (in shares) (219)   219      
Repurchase of common stock     $ (5,778)     (5,778)
Stock-based compensation expense   5,553       5,553
Comprehensive income (loss)       (4,150) (431) (4,581)
Balances (in shares) at Mar. 31, 2022 37,594   10,335      
Balances at Mar. 31, 2022 $ 6 430,799 $ (113,872) (101,871) (1,495) 213,567
Balances (in shares) at Dec. 31, 2021 37,411   10,003      
Balances at Dec. 31, 2021 $ 6 423,069 $ (104,705) (97,721) (1,064) $ 219,585
Issuance of common stock in connection with exercise of options (in shares)           109
Comprehensive income (loss)           $ (6,757)
Balances (in shares) at Sep. 30, 2022 37,295   11,153      
Balances at Sep. 30, 2022 $ 6 441,705 $ (132,966) (101,633) (3,909) 203,203
Balances (in shares) at Mar. 31, 2022 37,594   10,335      
Balances at Mar. 31, 2022 $ 6 430,799 $ (113,872) (101,871) (1,495) 213,567
Issuance of common stock in connection with exercise of options (in shares) 12          
Issuance of common stock in connection with exercise of options   113       113
Vesting of restricted stock units (in shares) 84          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     33      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (800)     (800)
Repurchase of common stock (in shares) (715)   715      
Repurchase of common stock     $ (16,693)     (16,693)
Stock-based compensation expense   3,872       3,872
Comprehensive income (loss)       (1,147) (1,037) (2,184)
Balances (in shares) at Jun. 30, 2022 36,975   11,083      
Balances at Jun. 30, 2022 $ 6 434,784 $ (131,365) (103,018) (2,532) 197,875
Issuance of common stock in connection with employee stock purchase plan (in shares) 92          
Issuance of common stock in connection with employee stock purchase plan   1,509       1,509
Issuance of common stock in connection with exercise of options (in shares) 22          
Issuance of common stock in connection with exercise of options   276       276
Vesting of restricted stock units (in shares) 206          
Purchases of treasury stock in connection with tax withholdings on restricted stock grants (in shares)     70      
Purchases of treasury stock in connection with tax withholdings on restricted stock grants     $ (1,601)     (1,601)
Stock-based compensation expense   5,136       5,136
Comprehensive income (loss)       1,385 (1,377) 8
Balances (in shares) at Sep. 30, 2022 37,295   11,153      
Balances at Sep. 30, 2022 $ 6 $ 441,705 $ (132,966) $ (101,633) $ (3,909) $ 203,203